COVID-19 was declared a “Public Health Emergency of International Concern” in March
2020. Since then, drastic measures were implemented to reduce the virus spread. These …

SARS-CoV-2 infection does undoubtedly represent a challenge for care of patients with lung
cancer. Since symptoms of infection may overlap with underlying condition, diagnosis must …

Importance During the initial outbreak of the COVID-19 pandemic, cancer clinical trial
participation decreased precipitously. Given the continued pandemic—especially the severe …

Abstract Background Evidence-based interventions (EBIs) could reduce cervical cancer
deaths by 90%, colorectal cancer deaths by 70%, and lung cancer deaths by 95% if widely …

Background The recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
outbreak has caused millions of deaths and greatly influenced the timely diagnosis and …

Background This study examines the impact that the COVID‐19 pandemic has had on
computed tomography (CT)‐based oncologic imaging utilization. Methods We …

Objective In the COVID‐19 crisis context, the main objective of the study is to investigate
factors associated with perceived concerns of change in long‐term cancer care in patients …

People at high risk of morbidity and mortality from coronavirus disease 2019 (COVID-19),
including patients dealing with malignancies and patients on immunosuppressive …

Background: Globally, cancer is the second leading cause of death, and it is estimated that
over 18· 1 million new cases are diagnosed annually. The COVID-19 pandemic has …

The COVID-19 pandemic has required the professional healthcare workforce not only to
adjust methods of delivering care safely but also act as a trusted sources of information …